Market Cap

ImmuPharma plc Market Capitalization:

£6.7 Million

GBP as of Jan. 1, 2024

US$8.5 Million

business ImmuPharma plc Company Profile

ImmuPharma plc Main Stock Listing

LSE: IMM

Market Capitalization History of ImmuPharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of ImmuPharma plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £6.7 M -23.38%
Jan. 1, 2023 £8.8 M -64.77%
Jan. 1, 2022 £24.8 M -35.64%
Jan. 1, 2021 £38.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

ImmuPharma plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

ImmuPharma plc has the following listings and related stock indices.


Stock: LSE: IMM

Stock: FSX: 25I

Stock: OTC: IMMPF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.